Gilberto Seco
Family Medicine · Miami, FLNPI 1760440457
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $350 of the $575 with a category attached, or 60.9%. Every reported general payment came from a single manufacturer, Novo Nordisk AS.
Across 2 payments — averaging $287.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$575
Across 624 payments — averaging $11,150 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$2.9M
- Novartis$1.3M
- Beigene, Ltd.$744K
- AstraZeneca$424K
- Alnylam Pharmaceuticals Inc.$270K
- Bayer$221K
- plus $1M from 14 others
What the payments were for
- Travel & lodging$22539%
- Food & beverage$35061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 2 | $575 |
How this compares
$575 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Miami
- Clifford KinderMiami$75K
- Robert GoubeauxMiami$67K
- Vanessa RojasMiami$50K
- Michelle PowellMiami$34K
- Ana EloseguiMiami$32K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.